Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects

G. Bronte, C. Rolfo, E. Giovannetti, G. Cicero, P. Pauwels, F. Passiglia, M. Castiglia, S. Rizzo, F. Lo Vullo, E. Fiorentino, J. van Meerbeeck, A. Russo

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)300-313
JournalCritical Reviews in Oncology / Hematology
Volume89
Issue number2
DOIs
Publication statusPublished - 2014

Cite this